{"id":740218,"date":"2023-03-15T08:07:04","date_gmt":"2023-03-15T12:07:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/"},"modified":"2023-03-15T08:07:04","modified_gmt":"2023-03-15T12:07:04","slug":"teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/","title":{"rendered":"Teknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development"},"content":{"rendered":"

\nAn AAV chromatography platform plus optimized custom buffer formulations yields a state-of-the-art offering for increased AAV recovery
\n<\/h2>\n
\n

HOLLISTER, Calif., March 15, 2023 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (\u201cTeknova\u201d) (Nasdaq: TKNO), and Sartorius BIA Separations, which is part of the international life science group Sartorius, today announced that the companies have entered into a collaboration arrangement that will help gene therapy companies streamline the downstream purification process. Teknova is a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, and Sartorius BIA Separations is a leading developer of monolith-based technologies for the separation and analysis of large biomolecules and viral particles.<\/p>\n

The collaboration highlights two essential components necessary for the successful recovery of empty and full AAV capsids during anion-exchange (AEX) purification: the separation technology and the buffer composition. With Sartorius BIA Separations\u2019 proprietary AAV platform designed to optimize the separation of viral particles, and Teknova\u2019s custom, high-quality buffer solutions developed to maximize capsid enrichment, the companies conducted a robust design of experiment (DOE) and successfully created a screening kit with optimized buffer formulations that drive consistency and increased purity when paired with the BIA CIMmultus\u00ae<\/sup> QA monolith.<\/p>\n

\u201cWe\u2019re thrilled to find a like-minded partner with Sartorius BIA Separations, a well-respected, global leader in monolith-based technologies who shares our vision of making solutions possible,\u201d said Stephen Gunstream, Teknova\u2019s President and Chief Executive Officer. \u201cThrough our collaboration, we\u2019re finding new tools to help our customers streamline the development of AAV therapies by optimizing their purification process and increasing the yield and purity of their AAV product.\u201d<\/p>\n

\u201cTeknova is the perfect partner for us as we explore robust, end-to-end solutions for our gene therapy customers seeking to achieve better results in the separation and analysis of viral particles,\u201d added Ale\u0161 \u0160trancar, Managing Director at Sartorius BIA Separations. \u201cBased on their ability to quickly manufacture high-quality, custom buffers that are consistent from batch to batch, we\u2019ve been able to reliably reproduce results and confidently target the discreet differences in empty and full AAV particles.\u201d<\/p>\n

Gene therapy companies focusing on AAV will be able to get all the required consumables and a protocol that will streamline and accelerate the downstream processing workflow, enabling them to discover novel breakthroughs faster. Teknova and Sartorius BIA Separations intend to continue developing data demonstrating improvements in AAV purification when using their combined methods.<\/p>\n

To learn more about how to benefit from the companies\u2019 findings or to participate in Teknova\u2019s Early Access Program for the AEX Buffer Screening Kit, visit www.teknova.com<\/a>. For more information about Sartorius BIA Separations CIMmultus QA monolith, visit www.sartorius.com<\/a>.<\/p>\n

\n ABOUT TEKNOVA<\/strong>
\n
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel therapies that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in cell and gene therapy, molecular diagnostics, and synthetic biology. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 200,000 square feet of state-of-the-art facilities, Teknova\u2019s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of novel therapies.<\/p>\n

\n ABOUT SARTORIUS BIA SEPARATIONS<\/strong>
\n
Sartorius BIA Separations is the leading developer of monolith technology and the exclusive producer of CIM\u00ae<\/sup> (Convective Interaction Media) chromatographic columns for the production, purification, and analysis of large biomolecules. The Company\u2019s multi-use research, production, and training facility is headquartered in Ajdov\u0161\u010dina, Slovenia, with sales and distribution offices located internationally. Sartorius BIA Separations\u2019 ongoing mission is to develop and produce CIM\u00ae<\/sup> monolithic columns of the highest quality and provide superior research and method development services for our customers. In addition, the Company now offers the highly versatile PATfix\u2122 HPLC system for producing analytical gradient separations.<\/p>\n


\n
\n \n <\/div>\n

\n
CONTACTS \u2013 Teknova\r\n\r\nInvestor Contacts\u00a0\r\nMatt Lowell\u00a0\r\nChief Financial Officer\u00a0\r\nmatt.lowell@teknova.com\r\n+1 831-637-1100\u00a0\r\n\r\nSara Michelmore\u00a0\r\nMacDougall Advisors\u00a0\r\nsmichelmore@macdougall.bio\u00a0\r\n+1 781-235-3060\u00a0\r\n\r\nMedia Contact\u00a0\r\nJennifer Henry\u00a0\u00a0\r\nSenior Vice President, Marketing\u00a0\r\njenn.henry@teknova.com\u00a0\r\n+1 831-313-1259<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"
An AAV chromatography platform plus optimized custom buffer formulations yields a state-of-the-art offering for increased AAV recovery HOLLISTER, Calif., March 15, 2023 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (\u201cTeknova\u201d) (Nasdaq: TKNO), and Sartorius BIA Separations, which is part of the international life science group Sartorius, today announced that the companies have entered into a collaboration arrangement that will help gene therapy companies streamline the downstream purification process. Teknova is a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, and Sartorius BIA Separations is a leading developer of monolith-based technologies for the separation and analysis of large biomolecules and viral particles. The collaboration highlights two essential components necessary for the … <\/p>\n
Continue reading “Teknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-740218","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTeknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Teknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"An AAV chromatography platform plus optimized custom buffer formulations yields a state-of-the-art offering for increased AAV recovery HOLLISTER, Calif., March 15, 2023 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (\u201cTeknova\u201d) (Nasdaq: TKNO), and Sartorius BIA Separations, which is part of the international life science group Sartorius, today announced that the companies have entered into a collaboration arrangement that will help gene therapy companies streamline the downstream purification process. Teknova is a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, and Sartorius BIA Separations is a leading developer of monolith-based technologies for the separation and analysis of large biomolecules and viral particles. The collaboration highlights two essential components necessary for the … Continue reading "Teknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-15T12:07:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQwNSM1NDYyMzE2IzIyMDk0OTQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Teknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development\",\"datePublished\":\"2023-03-15T12:07:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\\\/\"},\"wordCount\":688,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQwNSM1NDYyMzE2IzIyMDk0OTQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\\\/\",\"name\":\"Teknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQwNSM1NDYyMzE2IzIyMDk0OTQ=\",\"datePublished\":\"2023-03-15T12:07:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQwNSM1NDYyMzE2IzIyMDk0OTQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc4ODQwNSM1NDYyMzE2IzIyMDk0OTQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Teknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Teknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/","og_locale":"en_US","og_type":"article","og_title":"Teknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development - Market Newsdesk","og_description":"An AAV chromatography platform plus optimized custom buffer formulations yields a state-of-the-art offering for increased AAV recovery HOLLISTER, Calif., March 15, 2023 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (\u201cTeknova\u201d) (Nasdaq: TKNO), and Sartorius BIA Separations, which is part of the international life science group Sartorius, today announced that the companies have entered into a collaboration arrangement that will help gene therapy companies streamline the downstream purification process. Teknova is a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, and Sartorius BIA Separations is a leading developer of monolith-based technologies for the separation and analysis of large biomolecules and viral particles. The collaboration highlights two essential components necessary for the … Continue reading \"Teknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-15T12:07:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQwNSM1NDYyMzE2IzIyMDk0OTQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Teknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development","datePublished":"2023-03-15T12:07:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/"},"wordCount":688,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQwNSM1NDYyMzE2IzIyMDk0OTQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/","name":"Teknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQwNSM1NDYyMzE2IzIyMDk0OTQ=","datePublished":"2023-03-15T12:07:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQwNSM1NDYyMzE2IzIyMDk0OTQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc4ODQwNSM1NDYyMzE2IzIyMDk0OTQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teknova-and-sartorius-bia-separations-announce-collaboration-to-address-critical-pain-point-in-gene-therapy-process-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Teknova and Sartorius BIA Separations Announce Collaboration to Address\u00a0Critical Pain Point in Gene Therapy Process Development"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=740218"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/740218\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=740218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=740218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=740218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}